During the past decade, Internistische Gemeinschaftspraxis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Internistische Gemeinschaftspraxis" are "Dyslipidemia" (4 trials), "Hypercholesterolemia" (2 trials), "Type II Diabetes Mellitus" (2 trials), "Dyslipidemias" (1 trials) and "Hypercholesterolemia or Combined Dyslipidemia" (1 trials). Many other conditions were trialed in "Internistische Gemeinschaftspraxis" in a lesser frequency.

Most popular intervention types in "Internistische Gemeinschaftspraxis" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (6 trials), "Atorvastatin" (3 trials) and "Pravastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Internistische Gemeinschaftspraxis" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Internistische Gemeinschaftspraxis". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Internistische Gemeinschaftspraxis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Internistische Gemeinschaftspraxis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".